Status:
COMPLETED
Optimal Concentration of Remifentanil for NIM Tube Intubation With Low-dose NMBA
Lead Sponsor:
Kyungpook National University Chilgok Hospital
Conditions:
Thyroidectomy
Eligibility:
FEMALE
20-60 years
Phase:
NA
Brief Summary
During thyroid surgery, Intraoperative Neuromonitoring (IONM) plays a crucial role in preventing serious complications such as bilateral vocal cord paralysis. It achieves this by detecting damage to t...
Eligibility Criteria
Inclusion
- All female aged 20-60
- ASA (American Society of Anesthesiologists) physical status I or II
- who scheduled for thyroidectomy under intraoperative neuromonitoring with a nerve integrity monitoring tube (NIM tube)
Exclusion
- Patients anticipated to experience challenging intubation.
- Patients who have had an upper respiratory tract infection within the past 2 weeks.
- Patients with a history of heart, lung, and kidney diseases.
- Patients with a body mass index (BMI) of 30 kg/m² or higher.
- Patients currently taking analgesics.
- Patients expressing a desire not to participate in the study.
Key Trial Info
Start Date :
November 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2024
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT06162390
Start Date
November 20 2023
End Date
March 20 2024
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sung Hye Byun
Daegu, Daegu, South Korea, 41404